DrugDev just surpassed 2 billion in total payments to sites on behalf of sponsors and CROs worldwide.
Paying approximately $40M per month, DrugDev continues to lead payments to sites on behalf of sponsors and CROs.
While that money can’t get us a two-bedroom apartment in San Francisco, it does signal us as the premier payments provider in the industry when combined with our ten years experience in over 60 countries and 1,800 clinical trials.